Rheumatology
From the Journals
Low-dose steroids may not increase cardiovascular risk in rheumatoid arthritis
A daily prednisolone dose of less than 5 mg was not associated with increased cardiovascular risk, whereas a dose of 5 mg or more doubled the risk...
From the Journals
Tools may predict inflammatory arthritis in at-risk patients
The two tool scores could help determine who can be managed in primary care and who may qualify for intervention studies.
From the Journals
Could risk stratifying methotrexate users lead to less frequent testing?
A new prognostic model accurately predicts a patient’s risk of experiencing methotrexate toxicity, but more research is needed before clinical...
Feature
Could GLP-1 receptor agonists ease knee osteoarthritis pain, slow progression?
Weight loss is recommended for patients with knee osteoarthritis (KOA), and GLP-1 RAs are approved for weight loss. Early research suggests these...
From the Journals
SGLT2 inhibitors linked with fewer gout flares in diabetes
“SGLT2 inhibitors may offer distinct benefits,” making the drug class “a particularly attractive addition to current urate-lowering therapies.”
Conference Coverage
Rheumatology summit tackles racial disparities in lupus trials
Researchers and patients explore why so few Black individuals sign up for studies and highlight projects that aim to develop better strategies.
From the Journals
New clues arise to consequences of calcium crystal deposition in knee OA
Is calcification a cause or a consequence of knee OA? New research has some findings.
From the Journals
Transcutaneous vagus nerve stimulation on the ear proves ineffective in RA treatment
Experts say that these negative findings do not imply that other vagus nerve stimulation therapies will be unsuccessful.
Feature
Humira biosimilars: Five things to know
The launch of eight adalimumab biosimilars so far in 2023 ended Humira’s 20-year monopoly, but it’s not clear yet if these discounted drugs will...
Latest News
Remote teams offer chance to improve difficult-to-treat PsA
This difficult-to-treat cohort is discussed at ZOOM meetings, ranging from monthly to bimonthly, with two dermatologists, two rheumatologists, one...
Latest News
Keep depression, anxiety screening top of mind in patients with psoriatic disease
"Psoriasis patients are twice as likely to have depression, compared to those without psoriasis, and psoriasis patients are 33% more likely to...